Receptor for Activated C-Kinase 1, a Novel Interaction Partner of Type II Bone Morphogenetic Protein Receptor, Regulates Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension
Author(s) -
Anna Zakrzewicz,
Matthias Hecker,
Leigh M. Marsh,
Grażyna Kwapiszewska,
Bożeejman-Faleńczyk,
Lü Long,
Werner Seeger,
Ralph T. Schermuly,
Nicholas W. Morrell,
Rory E. Morty,
Oliver Eickelberg
Publication year - 2007
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.106.670026
Subject(s) - bone morphogenetic protein receptor , downregulation and upregulation , phosphorylation , myocyte , bmpr2 , microbiology and biotechnology , biology , cell growth , vascular smooth muscle , receptor , medicine , bone morphogenetic protein , endocrinology , smooth muscle , biochemistry , gene
Pulmonary arterial hypertension (PAH) is characterized by selective elevation of pulmonary arterial pressure. The pathological hallmark of PAH is the narrowing of pulmonary arterioles secondary to endothelial cell dysfunction and smooth muscle cell proliferation. Heterozygous mutations in BMPR2, encoding the type II bone morphogenetic protein receptor (BMPRII), were identified in PAH, suggesting that alterations to BMPRII function are involved in disease onset and/or progression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom